Lsv Asset Management - Net Worth and Insider Trading
Lsv Asset Management Net Worth
The estimated net worth of Lsv Asset Management is at least $245 Million dollars as of 2025-07-25. Lsv Asset Management is the 2102 Investment manager of Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd and owns about 13,252,000 shares of Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (HKSE:00874) stock worth over $245 Million. Details can be seen in Lsv Asset Management's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Lsv Asset Management has not made any transactions after 2021-04-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Lsv Asset Management
Lsv Asset Management Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Lsv Asset Management owns 1 companies in total, including Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (HKSE:00874) .
Click here to see the complete history of Lsv Asset Management’s form 4 insider trades.
Insider Ownership Summary of Lsv Asset Management
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| HKSE:00874 | Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd | 2021-04-15 | 2102 Investment manager |
Lsv Asset Management Latest Holdings Summary
Lsv Asset Management currently owns a total of 1 stock. Lsv Asset Management owns 13,252,000 shares of Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (HKSE:00874) as of April 15, 2021, with a value of $245 Million.
Latest Holdings of Lsv Asset Management
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| HKSE:00874 | Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd | 2021-04-15 | 13,252,000 | 18.46 | 244,631,920 |
Holding Weightings of Lsv Asset Management
Lsv Asset Management Form 4 Trading Tracker
According to the SEC Form 4 filings, Lsv Asset Management has made a total of 1 transactions in Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (HKSE:00874) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd is the acquisition of 66,000 shares on April 15, 2021, which cost Lsv Asset Management around $1 Million.
Insider Trading History of Lsv Asset Management
- 1
Lsv Asset Management Trading Performance
GuruFocus tracks the stock performance after each of Lsv Asset Management's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Lsv Asset Management is 23.67%. GuruFocus also compares Lsv Asset Management's trading performance to market benchmark return within the same time period. The performance of stocks bought by Lsv Asset Management within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Lsv Asset Management's insider trading performs compared to the benchmark.
Performance of Lsv Asset Management
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 15.69 | | | | | |
| Relative Return to S&P 500(%) | 15.61 | | | | | |
Lsv Asset Management Ownership Network
Ownership Network List of Lsv Asset Management
Ownership Network Relation of Lsv Asset Management
Lsv Asset Management Owned Company Details
What does Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd do?
Who are the key executives at Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd?
Lsv Asset Management is the 2102 Investment manager of Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd. Other key executives at Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd include 2502 Approved lending agent Citigroup Inc. , 2102 Investment manager LSV Asset Management , and 2101 Beneficial owner Norges Bank .
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (HKSE:00874) Insider Trades Summary
Over the past 18 months, Lsv Asset Management made no insider transaction in Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (HKSE:00874). Other recent insider transactions involving Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (HKSE:00874) include a net sale of 0 shares made by Citigroup Inc. ,
In summary, during the past 3 months, insiders sold 0 shares of Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (HKSE:00874) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (HKSE:00874) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (HKSE:00874)'s detailed insider trading history can be found in Insider Trading Tracker table.
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Insider Transactions
Lsv Asset Management Mailing Address
Above is the net worth, insider trading, and ownership report for Lsv Asset Management. Currently GuruFocus does not have mailing address information for Lsv Asset Management.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
